These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3387499)
1. Plasma homovanillic acid levels and subtyping of schizophrenia. Chang WH; Chen TY; Lee CF; Hung JC; Hu WH; Yeh EK Psychiatry Res; 1988 Mar; 23(3):239-44. PubMed ID: 3387499 [TBL] [Abstract][Full Text] [Related]
2. Pharmacoclinical correlations in schizophrenic patients treated with haloperidol decanoate: clinical evaluations, concentrations of plasma and red blood cell haloperidol and its reduced metabolite, and plasma homovanillic acid. Aymard N; Viala A; Stein I; Caroli F Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov; 19(7):1119-35. PubMed ID: 8787036 [TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients. Chang WH; Lin SK; Jann MW; Lam YW; Chen TY; Chen CT; Hu WH; Yeh EK Biol Psychiatry; 1989 Jul; 26(3):239-49. PubMed ID: 2742942 [TBL] [Abstract][Full Text] [Related]
4. Plasma homovanillic acid in schizophrenics: supportive evidence for the two-subtype hypothesis. Chen TY; Lee CF; Lung FW; Lee TC; Lin WL; Hu WH; Yeh EK; Chang WH Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):584-8. PubMed ID: 2571672 [TBL] [Abstract][Full Text] [Related]
5. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses]. Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M Encephale; 1995; 21(6):417-24. PubMed ID: 8674466 [TBL] [Abstract][Full Text] [Related]
6. Plasma catecholamine metabolites in schizophrenics: evidence for the two-subtype concept. Chang WH; Chen TY; Lin SK; Lung FW; Lin WL; Hu WH; Yeh EK Biol Psychiatry; 1990 Mar; 27(5):510-8. PubMed ID: 2310806 [TBL] [Abstract][Full Text] [Related]
7. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Davidson M; Kahn RS; Knott P; Kaminsky R; Cooper M; DuMont K; Apter S; Davis KL Arch Gen Psychiatry; 1991 Oct; 48(10):910-3. PubMed ID: 1929760 [TBL] [Abstract][Full Text] [Related]
8. Plasma homovanillic acid and treatment response in a large group of schizophrenic patients. Chang WH; Hwu HG; Chen TY; Lin SK; Lung FW; Chen H; Lin WL; Hu WH; Lin HN; Chien CP Schizophr Res; 1993 Oct; 10(3):259-65. PubMed ID: 8260444 [TBL] [Abstract][Full Text] [Related]
9. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics. Duncan E; Wolkin A; Angrist B; Sanfilipo M; Wieland S; Cooper TB; Rotrosen J Biol Psychiatry; 1993 Oct; 34(8):523-8. PubMed ID: 8274579 [TBL] [Abstract][Full Text] [Related]
10. Effects of haloperidol decanoate on plasma homovanillic acid in chronic schizophrenic patients. Chang WH; Lin SK; Juang DJ; Chen LC; Yang CH; Lane HY; Jann MW Biol Psychiatry; 1993 Apr; 33(7):557-9. PubMed ID: 8513043 [No Abstract] [Full Text] [Related]
11. Plasma catecholamine metabolites and early response to haloperidol. Bowers MB; Swigar ME; Jatlow PI; Goicoechea N J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216 [TBL] [Abstract][Full Text] [Related]
12. Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol. Galinowski A; Poirier MF; Aymard N; Leyris A; Beauverie P; Bourdel MC; Loo H Acta Psychiatr Scand; 1998 Jun; 97(6):458-66. PubMed ID: 9669519 [TBL] [Abstract][Full Text] [Related]
13. Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics. Kim YK; Kim L; Lee MS Schizophr Res; 2000 Sep; 44(3):165-75. PubMed ID: 10962218 [TBL] [Abstract][Full Text] [Related]
14. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia. Newcomer JW; Riney SJ; Vinogradov S; Csernansky JG Psychiatry Res; 1992 Mar; 41(3):191-202. PubMed ID: 1594706 [TBL] [Abstract][Full Text] [Related]
15. Plasma homovanillic acid as a predictor of response to neuroleptics. Davila R; Manero E; Zumarraga M; Andia I; Schweitzer JW; Friedhoff AJ Arch Gen Psychiatry; 1988 Jun; 45(6):564-7. PubMed ID: 3377643 [TBL] [Abstract][Full Text] [Related]
16. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients. Davidson M; Losonczy MF; Mohs RC; Lesser JC; Powchik P; Freed LB; Davis BM; Mykytyn VV; Davis KL Neuropsychopharmacology; 1987 Dec; 1(1):17-23. PubMed ID: 3509064 [TBL] [Abstract][Full Text] [Related]
17. Memory and plasma HVA changes in schizophrenia: are they episode markers? Gilbertson MW; Yao JK; van Kammen DP Biol Psychiatry; 1994 Feb; 35(3):203-6. PubMed ID: 8173021 [No Abstract] [Full Text] [Related]
18. Neuroleptic treatment, symptoms of schizophrenia, and plasma homovanillic acid concentrations revisited. Volavka J; Douyon R; Convit A; Czobor P; Cooper TB Arch Gen Psychiatry; 1992 Dec; 49(12):999-1000. PubMed ID: 1449388 [No Abstract] [Full Text] [Related]
19. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment. Pickar D; Labarca R; Doran AR; Wolkowitz OM; Roy A; Breier A; Linnoila M; Paul SM Arch Gen Psychiatry; 1986 Jul; 43(7):669-76. PubMed ID: 3718170 [TBL] [Abstract][Full Text] [Related]
20. Effects of single dose haloperidol administration on plasma homovanillic acid levels in normal subjects. Magliozzi JR; Doran AR; Gietzen DW; Olson AM; Maclin EL; Tuason VB Psychiatry Res; 1993 May; 47(2):141-9. PubMed ID: 8341767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]